Clinical Trial Update: Onabotulinum Toxin A (Botox) in the Treatment of Transfer Dysphagia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for onabotulinum toxin A (Botox) investigating treatment of transfer and oropharyngeal dysphagia, including cricopharyngeus muscle dysfunc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cricopharyngeus Muscle Dysfunction
• Dysphagia Late Effect of Stroke
• Oropharyngeal Dysphagia
• Transfer Dysphagia

Drugs mentioned

• Onabotulinum Toxin-A (onabotulinumtoxinA)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Transfer Dysphagia, Oropharyngeal Dysphagia | Phase 2, Phase 3 | Status: UNKNOWN